Literature DB >> 12126677

Arthroscopic ACL reconstruction: a 5-9 year follow-up.

A L Ruiz1, M Kelly, R W Nutton.   

Abstract

Arthroscopic ACL reconstruction has a satisfactory functional outcome of up to 90%, but there are few long-term prospective studies. This prospective study presents the outcomes of ACL reconstruction in terms of laxity, function and degenerative change, after a mean follow-up of 7 years. Function was assessed using the Lysholm and Tegner Activity Scores, laxity using the Stryker Knee Laxity Tester, employing maximum manual effort, and degenerative change was assessed as joint line narrowing on standardised radiographs. At latest follow-up, the mean Lysholm score improved from 70 to 87 and the Tegner from 4 to 7 (P<0.001). AP translation also improved (P<0.001). The incidence of early degenerative change was 50% and although this appeared to be associated with a previous meniscectomy, the correlation was not significant (P=0.06). In conclusion, the improved functional scores and laxity are sustained beyond 7 years but the 50% incidence of early degenerative change may be a cause for concern. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2002        PMID: 12126677     DOI: 10.1016/s0968-0160(02)00019-4

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  26 in total

1.  Health-related quality of life after anterior cruciate ligament reconstruction.

Authors:  Olle Månsson; Jüri Kartus; Ninni Sernert
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-11-16       Impact factor: 4.342

2.  Return to play guidelines after anterior cruciate ligament surgery.

Authors:  G Myklebust; R Bahr
Journal:  Br J Sports Med       Date:  2005-03       Impact factor: 13.800

3.  Augmentation technique with semitendinosus and gracilis tendons in chronic partial lesions of the ACL: clinical and arthrometric analysis.

Authors:  Roberto Buda; Alberto Ferruzzi; Francesca Vannini; Lisa Zambelli; Francesco Di Caprio
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-06-24       Impact factor: 4.342

Review 4.  Effects of the menstrual cycle on lower-limb biomechanics, neuromuscular control, and anterior cruciate ligament injury risk: a systematic review.

Authors:  Vivek Balachandar; Jan-Luigi Marciniak; Owen Wall; Chandrika Balachandar
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10

5.  Determining utility values in patients with anterior cruciate ligament tears using clinical scoring systems.

Authors:  Mazda Farshad; Christian Gerber; Thomas Szucs; Dominik C Meyer
Journal:  BMC Health Serv Res       Date:  2011-08-04       Impact factor: 2.655

6.  Gender and age based differences in behavioural patterns following anterior cruciate ligament injury.

Authors:  Aneesh J Dave; Darren B Chen; Bradley G Seeto; Samuel J MacDessi
Journal:  J Orthop       Date:  2018-05-07

7.  Knee laxity measurements after anterior cruciate ligament reconstruction, using either bone-patellar-tendon-bone or hamstring tendon autografts, with special emphasis on comparison over time.

Authors:  Mattias Ahldén; Jüri Kartus; Lars Ejerhed; Jón Karlsson; Ninni Sernert
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-07-03       Impact factor: 4.342

Review 8.  Ipsilateral graft and contralateral ACL rupture at five years or more following ACL reconstruction: a systematic review.

Authors:  Rick W Wright; Robert A Magnussen; Warren R Dunn; Kurt P Spindler
Journal:  J Bone Joint Surg Am       Date:  2011-06-15       Impact factor: 5.284

9.  The effect of patient and injury factors on long-term outcome after anterior cruciate ligament reconstruction.

Authors:  Robert A Magnussen; Kurt P Spindler
Journal:  Curr Orthop Pract       Date:  2011-01-01

Review 10.  Meniscus status at anterior cruciate ligament reconstruction associated with radiographic signs of osteoarthritis at 5- to 10-year follow-up: a systematic review.

Authors:  Robert A Magnussen; Alfred A Mansour; James L Carey; Kurt P Spindler
Journal:  J Knee Surg       Date:  2009-10       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.